-
Combined clinical and gene expression score identifies high-risk individuals among follicular lymphoma patients on immunotherapy
Study
EGAS00001002566
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
Gene expression profiling of nasopharyngeal carcinoma
Study
EGAS00001004542
-
Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance (H067)
Study
EGAS00001004363
-
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
Study
EGAS00001004366
-
Hyperhaploid Multiple Myeloma
Study
EGAS00001003203
-
SPECTA RP-1759-AYA Sarcoma cohort
Study
EGAS00001005840
-
tFL with a PMBL GE signature
Study
EGAS00001005870
-
Cerebrospinal fluid circulating tumour DNA allows the characterisation and monitoring of medulloblastoma
Study
EGAS00001004651
-
Multiple Myeloma Total Therapy trial patient sequencing
Study
EGAS00001003223
-
Patient-derived tumor organoids for personalized medicine in a rare case of hepatocellular carcinoma with neuroendocrine differentiation.
Study
EGAS00001005887
-
Long-read sequencing for cell-free DNA analysis (human)
Study
EGAS00001006328
-
Neuroblastoma and adrenal gland single-cell study
Study
EGAS00001004388
-
Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers
Study
EGAS00001006331
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Alveolar Rhabdomyosarcoma sequencing data
Study
EGAS00001005387
-
Integrative Profiling of T790M Negative EGFR Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Study
EGAS00001005389
-
A mechanistic classification of clinical phenotypes in neuroblastoma
Study
EGAS00001003244
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Characterizing the immune and genome landscapes for osteosarcoma
Study
EGAS00001003247
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Diffuse Intrinsic Pontine Glioma
Study
EGAS00001006353
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma
Study
EGAS00001003251
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase
Study
EGAS00001004455
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
Targeted sequencing of diffuse large B-cell lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005953
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Study
EGAS00001003255
-
Combined targeting of BRD4-associated Promoter Activation and NFKB Immunomodulation in ARID1A-mutated Gastric Adenocarcinoma
Study
EGAS00001006397
-
Cabozantinib Response in ETV6-NTRK3 G623R Positive Carcinoma HIPO-021
Study
EGAS00001004494
-
Targeted-capture sequencing (bam files) of 81 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005443
-
ENCORAFENIB COMBINED WITH BINIMETINIB FOR BRAFV600E-MUTATED RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE PHASE II GMMG-BIRMA TRIAL (Hipo_K08K)
Study
EGAS00001005973
-
Biallelic HMBS Inactivation Defines a Homogenous Clinico-Molecular Subtype of Hepatocellular Carcinoma
Study
EGAS00001005986
-
An epigenetic single-cell atlas of IDH-mutant glioma reveals the role of ATRX in shaping tumor composition
Study
EGAS00001004523
-
Changes in alternative splicing and associated neo-antigens due to therapy
Study
EGAS00001004524
-
Embryonal Rhabdomyosarcoma sequencing data
Study
EGAS00001005502
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy
Study
EGAS00001004545
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Study
EGAS00001006400
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Genomic landscape and molecularly-informed therapy in thymic carcinoma and other advanced thymic epithelial tumors (H021, HIPO)
Study
EGAS00001006408
-
Dynamic N6-methyladenosine Epitranscriptomic Landscape in Lung Adenocarcinoma
Study
EGAS00001005524
-
Osteosarcoma sequencing data
Study
EGAS00001005600